Autor: |
Adriana Pané, Alicia Molina-Andujar, Romina Olbeyra, Bárbara Romano-Andrioni, Laura Boswell, Enrique Montagud-Marrahi, Amanda Jiménez, Ainitze Ibarzabal, Judith Viaplana, Pedro Ventura-Aguiar, Antonio J. Amor, Josep Vidal, Lilliam Flores, Ana de Hollanda |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6030 |
ISSN: |
2077-0383 |
Popis: |
Obesity and kidney transplantation (KTx) are closely related. Obesity increases the risk of chronic kidney disease and can be a relative contraindication for KTx. Besides, KTx recipients are predisposed to obesity and its comorbidities. Consequently, bariatric surgery (BS) emerges as a powerful therapeutic tool either before or after KTx. Since evidence regarding the best approach is still scarce, we aimed to describe renal and metabolic outcomes in a single centre with more than 15-year experience in both surgeries. Methods: A retrospective study including patients who had received a KTx either before or after BS. Usual metabolic and renal outcomes, but also new variables (as renal graft dysfunction) were collected for a minimum follow-up of 1-year post-BS. Results: A total of 11 patients were included: n = 6 (BS-post-KTx) and n = 5 (BS-pre-KTx). One patient was assessed in both groups. No differences in the main outcomes were identified, but BS-post-KTx group tended to gain more weight during the follow-up. The incidence of renal graft dysfunction was comparable (4/6 for BS-post-KTx, 3/5 for BS-pre-KTx) between groups. Conclusions: BS in patients with KTx appears to be safe and effective attending to metabolic and renal outcomes. These results seem irrespective of the time course, except for weight regain, which appears to be a common pattern in the BS-post-KTx group. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|